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Synergistic assembly of human pre-
spliceosomes across introns and exons
Joerg E Braun1,2, Larry J Friedman2, Jeff Gelles2*, Melissa J Moore1*
1RNA Therapeutics Institute, University of Massachusetts Medical School,
Worcester, United States; 2Department of Biochemistry, Brandeis University,
Waltham, United States
Abstract Most human genes contain multiple introns, necessitating mechanisms to effectively
define exons and ensure their proper connection by spliceosomes. Human spliceosome assembly
involves both cross-intron and cross-exon interactions, but how these work together is unclear. We
examined in human nuclear extracts dynamic interactions of single pre-mRNA molecules with
individual fluorescently tagged spliceosomal subcomplexes to investigate how cross-intron and
cross-exon processes jointly promote pre-spliceosome assembly. U1 subcomplex bound to the 5’
splice site of an intron acts jointly with U1 bound to the 5’ splice site of the next intron to
dramatically increase the rate and efficiency by which U2 subcomplex is recruited to the branch
site/3’ splice site of the upstream intron. The flanking 5’ splice sites have greater than additive
effects implying distinct mechanisms facilitating U2 recruitment. This synergy of 5’ splice sites
across introns and exons is likely important in promoting correct and efficient splicing of multi-
intron pre-mRNAs.
DOI: https://doi.org/10.7554/eLife.37751.001
Introduction
Spliceosomes consist of the U1, U2, and U4/U6.U5 small nuclear ribonucleoproteins (snRNPs) and
multiprotein Prp19-complex as major building blocks, plus many transiently interacting splicing fac-
tors (Wahl et al., 2009). This machinery recognizes and assembles stepwise at splice sites (SS) (U1 at
5’SS and U2 at the 3’SS/branch site) to form pre-spliceosomes, which are subsequently remodeled
into catalytically active spliceosomes. Pre-spliceosomes can form on multi-intron pre-mRNAs through
at least two different pathways. An intron can be recognized a) via cross-intron interactions leading
directly to a catalytically active spliceosome, or b) via cross-exon interactions where the exons flank-
ing an intron are first defined, after which cross-intron interactions between adjacent cross-exon
complexes lead to spliceosome assembly (Moldo´n and Query, 2010). On human pre-mRNAs, which
characteristically harbor multiple long introns and short exons, exon definition predominates (Ber-
get, 1995; Fox-Walsh et al., 2005). Indeed, splicing is greatly enhanced when a 5’SS is present
across the exon downstream of an intron, highlighting the importance of exon definition in humans
(Talerico and Berget, 1990; Yue and Akusja¨rvi, 1999). Cross-exon pre-spliceosomes can transition
into cross-intron pre-spliceosomes, each having a distinct protein composition; the latter can then
productively splice the pre-mRNA (Chiara and Reed, 1995; Schneider et al., 2010). However, the
mechanisms by which cross-intron and cross-exon pre-spliceosomes work together to facilitate pre-
mRNA splicing remain unclear. In S. cerevisiae, where the cross-intron pathway predominates, sin-
gle-molecule approaches have proven invaluable for elucidating the kinetic pathways and subcom-
plex dynamics involved in spliceosome assembly (Semlow et al., 2016; Warnasooriya and Rueda,
2014). Here we developed the tools necessary to implement colocalization single-molecule spectros-
copy (CoSMoS) in human cell extracts and used this system to investigate the dynamic mechanism of
cross-intron and cross-exon cooperation in human pre-spliceosome assembly.
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Results
Single-molecule visualization of spliceosome assembly and function in
human cell extract
We began by investigating whether human nuclear extracts can assemble catalytically-competent
spliceosomes on surface-tethered pre-mRNA molecules. To do this, we utilized the pre-mRNA
model substrate PIP85A (Moore and Sharp, 1992) (Figure 1A, Table 1). We refer to this RNA here
as ‘5i3’ to indicate that, reading in the 5’-to-3’ direction, it contains a partial exon, a 5’SS (‘5’), an
intron (i), a 3’SS (‘3’), and another partial exon. For this pre-mRNA 20 ± 2% (s.d.) was converted to
spliced products after 40 mins in human cell line HEK293 nuclear extract (Figure 1B). No spliced
products were observed in the absence of ATP, which is required for spliceosome assembly. To
monitor splicing of individual 5i3 molecules, we incorporated a green-excited dye into the 5’ exon, a
red-excited dye into the intron, and biotin at the end of the 3’ exon (Figure 1C). We sparsely depos-
ited this pre-mRNA onto a streptavidin-functionalized glass surface, added nuclear extract and fol-
lowed green and red fluorescence from single pre-mRNA molecules over time. To exclude pre-
mRNAs that lost intron signal due to RNA degradation, we selected only those molecules retaining
5’ exon (green) fluorescence at the end of the 40 min experiment. Of these, 1.1 ± 0.7% (s.e.) lost
intron (red) fluorescence in a control conducted in the absence of ATP (likely due to photobleaching)
whereas 18 ± 4% (s.e.) lost intron fluorescence in the presence of ATP. This single-molecule assay
specifically monitors intron release, while the bulk assay measures the second splicing step. Intron
release requires an ATP-dependent structural rearrangement of the splicing machinery after the sec-
ond splicing step, so as expected the lag phase was somewhat longer in the single-molecule assay
(Figure 1C) than in the bulk splicing assay (Figure 1B). However, surface-tethered 5i3 pre-mRNA
molecules were spliced with a similar efficiency (17%) to what is observed in solution (20%).
To enable single-molecule visualization of individual spliceosomal subcomplexes, we generated
three HEK293 cell lines, each stably expressing C-terminally fSNAP-tagged U1-70K, U2B’, or Snu114
at a level comparable to the endogenous protein (Figure 1—figure supplement 1). Co-immunopre-
cipitation experiments confirmed efficient incorporation of the tagged protein into U1, U2, or U5
respectively (Figure 1—figure supplement 2). Treatment of nuclear extracts with a green-excited
dye-benzylguanine conjugate resulted in highly specific labeling of the fSNAP-tagged proteins
eLife digest A gene is a segment of DNA that usually carries the information required to build a
protein, the molecules responsible for most of life’s processes. This DNA segment is organized in
modules, with coding sections separated by portions of non-coding DNA known as introns.
When a gene is ‘turned on’, it gets faithfully copied into a molecule of pre-messenger RNA (pre-
mRNA), which contains the alternating coding and non-coding modules. Before it can serve as a
template to create a protein, this pre-mRNA must be processed and all the introns removed by a
structure called the spliceosome. If this delicate process goes wrong, inaccurate protein templates
are produced that may be damaging for the cell.
Spliceosomes are precise molecular ‘scissors’ that can recognize where a coding module stops
and an intron starts, and then make a snip in the pre-mRNA to remove the non-coding sequence.
The spliceosome is a complex molecular machine formed of numerous parts – including one known
as U1 snRNP – that must come together. When a pre-mRNA has several introns, a spliceosome
assembles anew for each of them.
Braun et al. designed a new method that allows them to ‘tag’ spliceosomes extracted from a
human cell and follow them as they come together. The experiments show that spliceosomes
working on different introns in the same pre-mRNA actually help each other out. As one assembles,
this helps the spliceosome that processes the neighboring intron to get built. In particular, the U1
snRNPs processing nearby introns collaborate to promote the assembly and activity of the
spliceosomes. This teamwork is likely important to guarantee that multiple introns are cut out
quickly and accurately.
DOI: https://doi.org/10.7554/eLife.37751.002
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(Figure 1—figure supplement 3). Because spliceosomal subcomplex concentrations in human
nuclear extracts exceed the low dye concentrations optimal for single-molecule fluorescence, we
labeled the tagged proteins using a limiting dye concentration (200 nM). Under these conditions,
30%, 60%, and 50% of total (tagged plus untagged) U1-70K, U2B’, and Snu114 were labeled,
respectively (Figure 1—figure supplement 4). Importantly, all tagged and dye-labeled extracts
exhibited bulk splicing efficiencies comparable to extracts from the untagged parental cell line (Fig-
ure 1—figure supplement 5).
Assembly of cross-intron and cross-exon pre-spliceosomes
We next used the labeled extracts in CoSMoS experiments in which we compared subcomplex
dynamics on individual RNAs designed to promote assembly of cross-intron or cross-exon pre-spli-
ceosomes (Figure 2A). The cross-intron RNA (5i3, Figure 2B) was identical to that in Figure 1
except that it contained a single red-excited dye adjacent to the biotin tether at the end of the 3’
exon. An identically-labeled cross-exon RNA (3e5, Figure 2B) was constructed by swapping the 5’
and 3’ halves of 5i3. Thus, 5i3 and 3e5 consist of identical sequence segments, and differ only by
whether the 5’ and 3’SS are separated by an intron (i) or an exon (e). Simultaneous presence of the
two RNA species at distinct, known locations on the slide surface allowed us to compare their
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Figure 1. Observing splicing of the PIP85A (5i3) model pre-mRNA (A) in bulk (B) and single-molecule (C) splicing assays. Introns and exons are
schematized as blue lines and rectangles, respectively, with A indicating the branchpoint. For bulk analysis (B) trace-labeled 5i3 was incubated with
nuclear extracts, aliquots were analyzed on denaturing gel (15%) and second step splicing products quantified in graph. Second step splicing efficiency
(±s.d.) was calculated as the amount of ligated exon product relative to the amount of 5i3 starting material at time zero. For single-molecule analysis
(C), dyes tethered to the surface (red, green stars) were visualized using total internal reflection fluorescence microscopy using alternating red and
green laser excitation (arrows); dye-labeled molecules in solution are not detectable. Fraction (±s.e.) of labeled introns remaining was calculated as the
fraction of the N molecules retaining the exon dye fluorescence (green star) through the entire experiment duration which retained intron dye
fluorescence (red star) at a particular time. Labeling of spliceosomal subcomplexes is shown in Figure 1—figure supplements 1–5.
DOI: https://doi.org/10.7554/eLife.37751.003
The following figure supplements are available for figure 1:
Figure supplement 1. Expression of fSNAP-fusion proteins in HEK293 cells.
DOI: https://doi.org/10.7554/eLife.37751.004
Figure supplement 2. Co-immunoprecipitation experiments show integration of fusion proteins into spliceosome assembly intermediates at
efficiencies similar to their endogenous untagged counterparts.
DOI: https://doi.org/10.7554/eLife.37751.005
Figure supplement 3. Spliceosomal subcomplex labeling in human nuclear extracts.
DOI: https://doi.org/10.7554/eLife.37751.006
Figure supplement 4. Labeling efficiencies for spliceosomal proteins.
DOI: https://doi.org/10.7554/eLife.37751.007
Figure supplement 5. Bulk splicing efficiency and protein concentration for the nuclear extracts used in this study.
DOI: https://doi.org/10.7554/eLife.37751.008
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Table 1. RNAs.
5 N-U, 5-aminoallyluridine. U-DY547, Dylight 547 dye conjugated to C5 of U through a six-carbon
linker. Small letters indicate mutated bases in the mutant sequence variants. The cryptic 5’SS in Xi3e5
(see Figure 4B) is underlined.
RNA name RNA sequence (5’ to 3’)
5i3 (cross-intron, PIP85A) GGGCGAAUUCGAGCUCACUCUCUUCCGCAUCGCUGUCUGCG
AGGUACCCUACCAGGUGAGUAUGGAUCCCUCUAAAAGCGGG
CAUGACUUCUAGAGUAGUCCAGGGUUUCCGAGGGUUUCCG
UCGACGAUGUCAGCUCGUCUCGAGGGCGUACUAACUGGGC
CCCUUCUUCUUUUUCCCUCAGGUCCUACACAACAUACUGCA
GGACAAACUCUUCGCGGUCUCUGCAUGCAA
Xi3 (cross-intron, 5’SS mutant) GGGCGAAUUCGAGCUCACUCUCUUCCGCAUCGCUGUCUGCG
AGGUACCCUACCccccGAGUAUGGAUCCCUCUAAAAGCGGGCA
UGACUUCUAGAGUAGUCCAGGGUUUCCGAGGGUUUCCGUCG
ACGAUGUCAGCUCGUCUCGAGGGCGUACUAACUGGGCCCCUU
CUUCUUUUUCCCUCAGGUCCUACACAACAUACUGCAGGACAA
ACUCUUCGCGGUCUCUGCAUGCAA
5iX (cross-intron, polypyrimidine
tract and 3’SS mutant)
GGGCGAAUUCGAGCUCACUCUCUUCCGCAUCGCUGUCUGCGA
GGUACCCUACCAGGUGAGUAUGGAUCCCUCUAAAAGCGGGCAU
GACUUCUAGAGUAGUCCAGGGUUUCCGAGGGUUUCCGUCGAC
GAUGUCAGCUCGUCUCGAGGGCGUACUAACUGGGCCgCUaCaU
gaUaUaCgCaCGGGUCCUACACAACAUACUGCAGGACAAACUCU
UCGCGGUCUCUGCAUGCAA
3e5 (cross-exon) GGGCGAAUUCGUCGACGAUGUCAGCUCGUCUCGAGGGCGUAC
UAACUGGGCCCCUUCUUCUUUUUCCCUCAGGUCCUACACAAC
AUACUGCAGGACAAACUCUUCGCGGUCUCUGCAUGCGAGCUC
ACUCUCUUCCGCAUCGCUGUCUGCGAGGUACCCUACCAGGU
GAGUAUGGAUCCCUCUAAAAGCGGGCAUGACUUCUAGAGUAG
UCCAGGGUUUCCGAGGGUUUCCAA
3eX (cross-exon, 5’SS mutant) GGGCGAAUUCGUCGACGAUGUCAGCUCGUCUCGAGGGCGUA
CUAACUGGGCCCCUUCUUCUUUUUCCCUCAGGUCCUACACA
ACAUACUGCAGGACAAACUCUUCGCGGUCUCUGCAUGCGAG
CUCACUCUCUUCCGCAUCGCUGUCUGCGAGGUACCCUACCc
cccGAGUAUGGAUCCCUCUAAAAGCGGGCAUGACUUCUAGAG
UAGUCCAGGGUUUCCGAGGGUUUCCAA
Xe5 (cross-exon, polypyrimidine
tract and 3’SS mutant)
GGGCGAAUUCGUCGACGAUGUCAGCUCGUCUCGAGGGCGU
ACUAACUGGGCCgCUaCaUgaUaUaCgCaCgGGUCCUACACA
ACAUACUGCAGGACAAACUCUUCGCGGUCUCUGCAUGCGA
GCUCACUCUCUUCCGCAUCGCUGUCUGCGAGGUACCCUAC
CAGGUGAGUAUGGAUCCCUCUAAAAGCGGGCAUGACUUCU
AGAGUAGUCCAGGGUUUCCGAGGGUUUCCAA
5i3e5 GGGCGAAUUCGAGCUCACUCUCUUCCGCAUCGCUGUCUGC
GAGGUACCCUACCAGGUGAGUAUGGAUCCCUCUAAAAGCGG
GCAUGACUUCUAGAGUAGUCCAGGGUUUCCGAGGGUUUCC
GUCGACGAUGUCAGCUCGUCUCGAGGGCGUACUAACUGGG
CCCCUUCUUCUUUUUCCCUCAGGUCCUACACAACAUACUG
CAGGACAAACUCUUCGCGGUCUCUGCAUGCGAGCUCACUC
UCUUCCGCAUCGCUGUCUGCGAGGUACCCUACCAGGUGA
GUAUGGAUCCCUCUAAAAGCGGGCAUGACUUCUAGAGUA
GUCCAGGGUUUCCGAGGGUUUCCGACAAUUGCAUGAA
5i3eX GGGCGAAUUCGAGCUCACUCUCUUCCGCAUCGCUGUCUG
CGAGGUACCCUACCAGGUGAGUAUGGAUCCCUCUAAAAGC
GGGCAUGACUUCUAGAGUAGUCCAGGGUUUCCGAGGGUU
UCCGUCGACGAUGUCAGCUCGUCUCGAGGGCGUACUAAC
UGGGCCCCUUCUUCUUUUUCCCUCAGGUCCUACACAACA
UACUGCAGGACAAACUCUUCGCGGUCUCUGCAUGCGAGC
UCACUCUCUUCCGCAUCGCUGUCUGCGAGGUACCCUACC
ccccGAGUAUGGAUCCCUCUAAAAGCGGGCAUGACUUCUA
GAGUAGUCCAGGGUUUCCGAGGGUUUCCGACAAUUGCAUGAA
Table 1 continued on next page
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behavior under identical experimental conditions within a single reaction chamber (Figure 2C). After
introducing extract containing dye-labeled U1, we monitored the binding and dissociation of labeled
U1 to individual RNA molecules and to control locations that had no RNA (e.g., Figure 2D). Similar
experiments were performed using U2- and U5-labeled extracts.
To quantitatively characterize subcomplex binding to the surface tethered RNAs, we measured
both the frequency of RNA-specific subcomplex binding events and the steady-state fractional occu-
pancy RNA molecules by the subcomplex. U1 binding to 5i3 RNA was highly dynamic with many
arrivals and departures per active RNA molecule (Figure 2E–G) and a high frequency of short (<50
s) binding events (Figure 2F and H). In comparison, progressively fewer 5i3 molecules bound U2
and U5 and the average occupancy of RNAs by these subcomplexes was also progressively lower
(Figure 2F and I). Observed binding events were almost entirely RNA-specific; fewer and only short-
duration binding events were observed at control ‘no RNA’ locations (Figure 2—figure supplement
1). Overall, the kinetics of human spliceosomal subcomplex binding and dissociation on the cross-
intron 5i3 substrate were similar to those observed in CoSMoS experiments on cross-intron RNAs in
S. cerevisiae extracts (Hoskins et al., 2011; Shcherbakova et al., 2013).
Spliceosomal subcomplex interactions with the cross-exon 3e5 RNA were quantitatively different
from interactions with the cross-intron 5i3 RNA. 3e5 RNA molecules exhibited more frequent bind-
ing events (Figure 2F and G) and higher mean occupancy (Figure 2I) for all subcomplexes than 5i3
molecules. These differences might be partially explained by the inability of the cross-exon pre-
mRNA to form a catalytically active spliceosome (Figure 2—figure supplement 2), resulting in the
greater accumulation of inactive spliceosome assembly intermediates at steady state. Consistent
with this idea, U1, U2 and U5 exhibited a higher frequency of long-lived (>50 s) binding events on
the splicing-inactive 3e5 RNA than on the spliceable cross-intron 5i3 RNA (Figure 2H). In addition,
possible differences between 5i3 and 3e5 three-dimensional structures could also alter the kinetics
of their interactions with snRNPs.
We next investigated the effects of SS consensus sequence mutations on U1 and U2 binding
dynamics. We restricted alterations to short consensus subcomplex binding sequences to reduce the
Table 1 continued
RNA name RNA sequence (5’ to 3’)
Xi3e5 GGGCGAAUUCGAGCUCACUCUCUUCCGCAUCGCUGUCU
GCGAGGUACCCUACCccccGAGUAUGGAUCCCUCUAAAAG
CGGGCAUGACUUCUAGAGUAGUCCAGGGUUUCCGAGGG
UUUCCGUCGACGAUGUCAGCUCGUCUCGAGGGCGUACU
AACUGGGCCCCUUCUUCUUUUUCCCUCAGGUCCUACAC
AACAUACUGCAGGACAAACUCUUCGCGGUCUCUGCAUG
CGAGCUCACUCUCUUCCGCAUCGCUGUCUGCGAGGUAC
CCUACCAGGUGAGUAUGGAUCCCUCUAAAAGCGGGCAU
GACUUCUAGAGUAGUCCAGGGUUUCCGAGGGUUUCCG
ACAAUUGCAUGAA
Xi3eX GGGCGAAUUCGAGCUCACUCUCUUCCGCAUCGCUGUC
UGCGAGGUACCCUACCccccGAGUAUGGAUCCCUCUAA
AAGCGGGCAUGACUUCUAGAGUAGUCCAGGGUUUCCG
AGGGUUUCCGUCGACGAUGUCAGCUCGUCUCGAGGGC
GUACUAACUGGGCCCCUUCUUCUUUUUCCCUCAGGUC
CUACACAACAUACUGCAGGACAAACUCUUCGCGGUCUC
UGCAUGCGAGCUCACUCUCUUCCGCAUCGCUGUCUGC
GAGGUACCCUACCccccGAGUAUGGAUCCCUCUAAAAGC
GGGCAUGACUUCUAGAGUAGUCCAGGGUUUCCGAGGG
UUUCCGACAAUUGCAUGAA
S1 GGGCGAAUUCGAGCUCACUCUCUUCCGCAUCGCUGUCUG
S2 CGAGGUACC(U-DY547)UACCAGGUGA
S3 GUAUGGAUCCCUC(5 N-U)AAAAGCGGGCA(5 N-U)GACU
UCUAGAG(5 N-U)AGUCCAGGGUUUCCGA
S4 GGGUUUCCGUCGACGAUGUCAGCUCGUCUCGAGGGCGU
ACUAACUGGGCCCCUUCUUCUUUUUCCCUCAGGUCCUA
CACAACAUACUGCAGGACAAACUCUUCGCGGUCUCUGCAUGCAA
DOI: https://doi.org/10.7554/eLife.37751.027
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Figure 2. CoSMoS monitoring of spliceosomal subcomplex interactions with individual cross-intron (5i3) and cross-exon (3e5) pre-mRNA molecules in
human nuclear extracts. (A) Schematic of a CoSMoS experiment in which green dye-labeled U1 is observed binding to red dye-labeled, surface-
tethered RNAs. Introns and exons are schematized as blue and magenta lines and rectangles, respectively, with A indicating the branchpoint. Dyes
(stars) linked to tethered RNAs were visualized using total internal reflection fluorescence microscopy using alternating red and green laser excitation
Figure 2 continued on next page
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possibility of the mutations causing large-scale changes in the three-dimensional structures of the
RNAs. Functional U2 association with pre-mRNA depends on a polypyrimidine tract and the 3’SS AG
(Ruskin et al., 1988). As expected, multiple pyrimidine to purine substitutions within the polypyrimi-
dine tract combined with a 3’SS AG to GG mutation (Figure 3A) greatly decreased the frequencies
of RNA-specific U2 binding events, reducing binding to near-background levels (Figure 3—figure
supplement 1). U1 binding, however, was largely unaffected by these mutations, with U1 specific
association frequencies and dwell time distributions on 5iX and Xe5 RNAs indistinguishable from
those on 5i3 and 3e5, respectively (Figure 3B and Figure 3—figure supplement 2). Thus, consistent
with previous cross-intron data in yeast (Se´raphin and Rosbash, 1991), human U1 binding is inde-
pendent of U2 binding in both cross-intron and cross-exon contexts.
Functional U1 association is blocked by mutation of the 5’SS consensus from AG/GU to CCCC
(Roca et al., 2013). As expected, this mutation (Figure 3C) decreased the U1 association rate and
eliminated RNA-specific long-duration (>60 s) U1 binding events in both cross-intron and cross-exon
contexts (Figure 3—figure supplement 3). Thus long-duration U1 binding events reflect its associa-
tion with the canonical 5’SS, as reported previously in S. cerevisiae extract (Larson and Hoskins,
2017). In contrast, short duration U1 binding events are still present (although reduced in frequency)
after 5’SS mutation and may reflect sequence non-specific interactions with the RNA.
Surprisingly, the 5’SS mutations affected U2 binding even more strongly than U1 binding. In both
the cross-intron and cross-exon contexts, elimination of the canonical 5’SS decreased U2 binding fre-
quency to background within experimental uncertainty (Figure 3D and Figure 3—figure
Figure 2 continued
(arrows); dye-labeled molecules in solution are not detectable. (B) Schematic of 5i3 and 3e5 RNAs, with features indicated as in (A). See Table 1 for
RNA sequences. (C) Protocol: 5i3 (blue) and 3e5 (magenta) RNAs were sequentially deposited and located (squares) under red laser excitation. Non-
overlapping control ‘no RNA’ locations (gray) were selected. Then, extract was introduced and spliceosomal subcomplex (e.g., U1) binding to individual
RNA molecules was visualized under green laser excitation. Images (grayscale) are a small portion (2.6 mm x 2.6 mm) of the microscope field of view
recorded at each stage of the process. See Figure 2—figure supplement 3 for complete field of view. (D) Time series images (1 s per frame; 1.3 mm x
1.3 mm) of U1 fluorescence from example surface locations containing a single 5i3 RNA (top), a single 3e5 RNA (middle) or no detected RNA (bottom).
Images with fluorescence spots (highlighted) indicate U1 binding. See Figure 2—figure supplement 4 for additional traces and detected events. (E)
Rastergrams aggregating U1, U2, and U5 binding time courses from random samples of 50 individual 5i3 and 3e5 RNA molecules over 2,400 s. Each
row in these plots contains data from a single RNA molecule; color indicates presence and white indicates absence of bound spliceosomal
subcomplex. In each panel, RNA molecules are sorted by the time of first subcomplex binding (latest to earliest); the percentage (±s.e.) of N observed
RNA molecules that exhibited subcomplex binding during the experiment is indicated. Rastergrams for ‘no RNA’ control locations are shown in
Figure 2—figure supplement 1. (F) Cumulative distributions of U1, U2, and U5 dwell times on N observed 5i3 and 3e5 RNAs or control ‘no RNA’
locations. Data show the mean frequency per RNA molecule (or per ‘no RNA’ location) of subcomplex binding events with durations greater than or
equal to the indicated dwell time. All frequencies on RNAs are substantially higher than the non-specific binding seen at ‘no RNA’ locations (note
logarithmic scale). (G) Total frequencies (±s.e.) per RNA molecule of RNA-specific subcomplex binding. These RNA-specific binding frequencies
correspond to the RNA minus the no RNA vertical axis intercepts of the curves in (F); they represent the total rate of subcomplex-RNA binding
throughout the 2,400 s experiment averaged over all observed RNA molecules. (H) Frequencies (±s.e.) per RNA molecule of the subsets of RNA-specific
subcomplex binding events shorter or longer than 50 s. (I) Specific occupancy (±s.e.), corresponding to the fraction of RNA molecules bound by the
indicated fluorescent subcomplex averaged over the duration of the experiment. Numbers of RNA molecules observed in (G–I) are the same as those
reported in (F). The specific occupancy values are calculated as described (see Materials and methods) to correct for the small amount of binding
observed at ‘no RNA’ locations. Source data for Figure 2: SourceDataFigure2.zip.
DOI: https://doi.org/10.7554/eLife.37751.009
The following source data and figure supplements are available for figure 2:
Source data 1. Data from the single-molecule experiments.
DOI: https://doi.org/10.7554/eLife.37751.012
Figure supplement 1. Rastergrams of each subcomplex binding to 50 randomly selected ’no RNA’ control locations.
DOI: https://doi.org/10.7554/eLife.37751.010
Figure supplement 2. Bulk assay detects no splicing of 3e5 pre-mRNA.
DOI: https://doi.org/10.7554/eLife.37751.011
Figure supplement 3. Complete microscope field of view (48 mm x 49 mm, grayscale) containing the region shown in Figure 2C (yellow box).
DOI: https://doi.org/10.7554/eLife.37751.013
Figure supplement 4. Sample fluorescence intensity traces and detected U1 binding events on 5i3 and 3e5 RNA molecules and at no RNA control
locations (see Figure 2).
DOI: https://doi.org/10.7554/eLife.37751.014
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Figure 3. Interdependence of U1 and U2 binding to cross-intron and cross-exon RNAs. (A) Schematics of 5i3 and 3e5 RNAs without or with
polypyrimidine tract and 3’SS mutations (X). See Table 1 for RNA sequences. (B) Dynamics of dye labeled U1 binding to the RNAs depicted in (A), in a
CoSMoS experiment in which all four RNAs were simultaneously present. Cumulative dwell time distributions and frequencies of RNA-specific binding
were measured and plotted as in Figure 2F and G. For clarity, pairs of distributions are plotted in separate left and right panels and the no RNA data
from the experiment is shown in both. Corresponding rastergrams are shown in Figure 3—figure supplement 2. (C) Schematics of 5i3 and 3e5 RNAs
without or with 5’SS mutations (X). (D) Dynamics of dye-labeled U2 binding in two separate CoSMoS experiments, one with 5i3 and Xi3 RNAs (left) and
one with 3e5 and 3eX (right). Corresponding rastergrams are shown in Figure 3—figure supplement 4. Dependence of U1 binding on 5’SS mutations
and dependence of U2 binding on polypyrimidine tract and 3’SS mutations are shown in Figure 3—figure supplement 1 and Figure 3—figure
supplement 3 respectively. Source data for the single-molecule experiments in Figure 3, Figure 3—figure supplement 1, Figure 3—figure
supplement 3, Figure 3—figure supplement 5, and Figure 3—figure supplement 6: SourceDataFigure3.zip, SourceDataFigure3S1.zip,
SourceDataFigure3S3.zip, SourceDataFigure3S5.zip, and SourceDataFigure3S6.zip.
DOI: https://doi.org/10.7554/eLife.37751.015
The following source data and figure supplements are available for figure 3:
Source data 1. Data from the single-molecule experiments.
DOI: https://doi.org/10.7554/eLife.37751.022
Figure supplement 1. U2 binding events to pre-mRNA depend on the polypyrimidine tract and 3’SS.
DOI: https://doi.org/10.7554/eLife.37751.016
Figure supplement 1—source data 1. Data from the single-molecule experiments.
DOI: https://doi.org/10.7554/eLife.37751.023
Figure supplement 2. Rastergrams showing U1 binding to 50 randomly selected 5i3, 5iX, 3e5, and Xe5 pre-mRNA molecules and ’no RNA’ control
locations over the course of 2,400 s, sorted by the time of the first binding event.
DOI: https://doi.org/10.7554/eLife.37751.017
Figure supplement 3. Long-duration U1 binding to pre-mRNA depends on a canonical 5’SS.
DOI: https://doi.org/10.7554/eLife.37751.018
Figure supplement 3—source data 2. Data from the single-molecule experiments.
DOI: https://doi.org/10.7554/eLife.37751.024
Figure supplement 4. Rastergrams showing U2 binding data on 50 randomly selected individual 5i3, Xi3, 3e5, and 3eX pre-mRNA molecules and
control ’no RNA’ locations over the course of 2,400 s, sorted by the time of the first binding event to each RNA or location.
Figure 3 continued on next page
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supplement 4). Absence of U5 binding to these RNAs (Figure 3—figure supplement 5) confirmed
that the mutations abolished the formation of functional pre-spliceosomes. These observations could
indicate that observable U2 binding requires the U1 binding to a 5’SS positioned either cross-exon
or cross-intron. Alternatively the results could also be explained if the 5’SS mutation indirectly affects
U2 binding by affecting the pre-mRNA secondary structure. To exclude the latter possibility, we
demonstrated U2 binding to the 5i3 and 3e5 was also eliminated in experiments (Figure 3—figure
supplement 6) in which U1 interaction with the 5’SS was blocked by the addition of a morpholino
oligonucleotide antisense to the U1 snRNA (Kaida et al., 2010). We conclude that U2 binding to the
3’SS is strongly dependent on U1 binding to a 5’SS either upstream (cross-intron) or downstream
(cross-exon). This suggests an ordered human pre-spliceosome assembly pathway in which stable U2
association in the presence of ATP requires prior U1 binding, in contrast to the branched pathway
observed in S. cerevisiae (Shcherbakova et al., 2013).
Synergistic effects of cross-intron and cross-exon 5’SS on pre-
spliceosome assembly
In multi-intron pre-mRNAs, internal exons have 5’SS both upstream and downstream, either or both
of which could bind U1 and act to recruit U2 to the 3’SS. In principle, the two U1s could act either
independently or synergistically. If there is only one means by which U1 can recruit U2 (e.g., via bind-
ing to a single site on U2), the combined effect of two U1s on U2 binding would be at most the sum
of their individual actions (Herschlag and Johnson, 1993). Such is the case for the activities of multi-
ple SR proteins on splicing efficiency (Graveley et al., 1998). In contrast, if the upstream and down-
stream U1s can interact with U2 simultaneously, or if they accelerate different steps in the overall U2
recruitment process, their combined effect could be larger, that is, synergistic. Such synergy was
previously observed between two distinct sequence elements within a regulated splicing enhancer
(Lynch and Maniatis, 1995).
To determine whether the upstream and downstream 5’SS independently or synergistically pro-
mote U2 binding, we constructed a pre-mRNA with 5’SS both upstream and downstream of the 3’SS
(5i3e5, Figure 4A) as well as RNAs with mutations in either one 5’SS (Xi3e5 and 5i3eX) or both
(Xi3eX). In these constructs, the sequences flanking both 5’SS were identical, minimizing potential
sequence context effects. Consistent with the concept of exon definition (Talerico and Berget,
1990), splicing of 5i3e5 was 5-fold more efficient than 5i3eX in ensemble splicing reactions
(Figure 4B). In fact, the effect of adding the downstream 5’SS was strong enough to activate an oth-
erwise dormant cryptic 5’SS in the Xi3e5 construct. As expected, no splicing was observed on Xi3eX
RNA.
We next performed single-molecule observations of U2 binding to these same four RNAs, all
tethered and observed in a single reaction chamber to facilitate their direct comparison. Consistent
with the observation that U2 binding in the cross-intron and cross-exon contexts depends on a 5’SS
(Figure 3C and D), no U2 binding above background levels was observed for the RNA with no 5’SS
(Xi3eX) (Figure 4C and Figure 4—figure supplement 1). Additionally, the shapes of the U2 dwell
time distributions on 5i3eX and Xi3e5 (Figure 4C) were similar to those of the shorter 5i3 cross-
intron and 3e5 cross-exon constructs (Figure 2F). Thus, the 5’SS dependence of U2 binding seen
with the longer RNAs was qualitatively similar to that observed on the previously characterized
shorter RNAs.
Figure 3 continued
DOI: https://doi.org/10.7554/eLife.37751.019
Figure supplement 5. U5 binding to 5i3 pre-mRNA depends on the 5’SS.
DOI: https://doi.org/10.7554/eLife.37751.020
Figure supplement 5—source data 3. Data from the single-molecule experiments.
DOI: https://doi.org/10.7554/eLife.37751.025
Figure supplement 6. Antisense morpholino oligonucleotide (AMO) targeting U1 snRNA strongly reduces U2 binding to both 5i3 and 3e5 RNAs.
DOI: https://doi.org/10.7554/eLife.37751.021
Figure supplement 6—source data 4. Data from the single-molecule experiments.
DOI: https://doi.org/10.7554/eLife.37751.026
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Striking differences were apparent, however, when we compared the single 5’SS RNAs (Xi3e5
and 5i3eX) to the double 5’SS RNA (5i3e5) (Figure 4C and Figure 4—figure supplement 1). The
presence of flanking 5’SS both upstream and downstream of the 3’SS dramatically increased U2
recruitment, with the RNA-specific U2 binding event frequency being more than 2.5 times the sum
of the frequencies observed when either the upstream or downstream 5’SS was present alone. A
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Figure 4. Synergistic recruitment of U2 by 5’SS across introns and exons. (A) Schematic of 5i3e5 RNAs without or
with 5’SS mutations (X). Black brackets indicate two regions (113 nts) of identical sequence. (B) Ensemble splicing
time courses of 32P-labeled RNA. Second step splicing efficiencies (±s.d.) were calculated as fraction of 5i3e5,
5i3eX, Xi3e5 and Xi3eX starting material at time zero. Arrow indicates 5’ exon resulting from usage of a cryptic
5’SS 12 nts upstream of the canonical 5’SS in Xi3e5. (C) Cumulative dwell time distributions, RNA-specific binding
frequencies (±s.e.) and time-averaged fractional occupancies (±s.e.) of U2 binding to 5i3e5, 5i3eX, Xi3e5 and Xi3eX
RNAs measured in the same experiment. Corresponding rastergrams are shown in Figure 4—figure supplement
1. Analysis of time of first U2 binding event distributions is shown in Figure 4—figure supplement 2. Source data
for the single-molecule experiments in Figure 4: SourceDataFigure4.zip.
DOI: https://doi.org/10.7554/eLife.37751.028
The following source data and figure supplements are available for figure 4:
Source data 1. Data from the single-molecule experiments.
DOI: https://doi.org/10.7554/eLife.37751.031
Figure supplement 1. Rastergrams showing U2 binding data on 50 randomly selected individual 5i3e5, 5i3eX,
Xi3e5, and Xi3eX pre-mRNA molecules and control ’no RNA’ locations from the experiment shown in Figure 4C,
sorted by the time to the first binding observed on each RNA.
DOI: https://doi.org/10.7554/eLife.37751.029
Figure supplement 2. Cumulative distributions of the fraction of RNA molecules exhibiting at least one U2
binding event by the indicated time after the start of the experiment.
DOI: https://doi.org/10.7554/eLife.37751.030
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similar effect was seen in the U2 occupancy measurements (Figure 4C), although the occupancy
data is more difficult to interpret due to splicing via the cryptic splice site in Xi3e5. A much greater
than additive effect was also seen when we compared the distributions of the time to the first U2
binding observed on each RNA (Figure 4—figure supplement 2), a metric that is comparatively
immune to artefacts from spot detection dropouts (Friedman and Gelles, 2015). Taken together,
these data indicate that the upstream and downstream 5’SS act synergistically to accelerate the rate
of stable U2 recruitment to the 3’SS.
Discussion
Here we establish methods for observing the dynamics of spliceosomal subcomplexes on and the
splicing of individual pre-mRNA molecules in human cell extract. The experiments reveal that the
dynamics of U1 binding to the 5’SS are largely unaffected by the presence of U2 binding sites posi-
tioned either downstream (cross-exon) or upstream (cross-intron) of the 5’SS. In contrast, stable U2
binding to the 3’SS is accelerated by a 5’SS situated across either the adjacent intron or adjacent
exon. Strikingly, when functional 5’SS are present together at both cross-intron and cross-exon loca-
tions, they synergistically promote U2 recruitment.
The more than additive effect of the flanking 5’SS indicates that U1 employs different molecular
mechanisms/interactions across introns and across exons to accelerate U2 recruitment. A simple
model that would explain this observed synergy of cross-exon and cross-intron 5’SS on U2 recruit-
ment rate is that cross-exon U1 binding assists in recruiting the splicing factors that form a platform
for U2 binding to the upstream 3’SS region, whereas the cross-intron U1-U2 interaction favors a U2
conformation capable of productive branch site engagement (Figure 5, left). Across exons, U1 is
known to recruit U2AF (U2 auxiliary factor), which recognizes the polypyrimidine tract and 3’SS AG,
and physically interacts with other proteins (e.g., SF1, p14, SF3B and SR proteins) required for stable
U2 binding (Black, 2003). Across introns, U1 and U2 can interact via the DEAD-box protein Prp5,
the ATPase activity of which promotes a structural change in U2 that makes the branch site recogni-
tion sequence more solvent accessible (Abu Dayyeh et al., 2002; O’Day et al., 1996; Xu et al.,
2004). A different and not necessarily mutually exclusive model is that cross-exon and cross-intron
A
U1
A
U1
A
A
U2
U1
U2
U1 U1
U1
U1 U2
U1
Figure 5. Implications of synergistic U2 recruitment for the mechanism of exon and intron recognition. The
cartoon illustrates how differing modes of U1 action from upstream (cross-intron) and downstream (cross-exon)
sites can synergize to promote faster U2 binding when both flanking U1 sites are present. Double-headed arrows
denote physical interactions in which one component may accelerate association or slow dissociation of another.
DOI: https://doi.org/10.7554/eLife.37751.032
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U1 interactions could both help form the binding platform for U2, but by interacting with different
proteins (e.g., the upstream U1 stabilizes SF1 and the downstream U1 stabilizes U2AF) (Black, 2003).
This arrangement would increase the likelihood of U2 encountering a fully assembled binding plat-
form when in a conformation capable of stable branch site engagement (Figure 5, right). Other
mechanisms for synergy, such as those mediated by effects on RNA secondary structure, are also
possible.
Models of the type presented in Figure 5 assume that once a functional U1-U2 pre-spliceosome
forms across the intron, interactions with U1 bound to the downstream 5’SS provide no additional
U2 binding stabilization or stimulation of subsequent steps of spliceosome assembly (Figure 5, bot-
tom). Such models predict that the presence of a downstream U1 will not affect the lifetimes of sta-
ble U2 complexes once formed. The data in Figure 4C are consistent with this prediction: both the
overall shape of dwell time distributions and the ratios of binding frequency to occupancy are similar
for the RNAs with (5i3e5: 1.0 ± 0.2 s 1) or without (5i3eX: 1.3 ± 0.9 s 1) the downstream site. Taken
Table 2. Oligonucleotides and antisense morpholino oligonucleotides (AMO).
m, 2’-O-methyl ribonucleotide; 3ddN, 3’ dideoxy nucleotide.
Oligonucleotide name Oligonucleotide sequence (5’ to 3’)
fSNAP-F AGAGATAAGCTTTCCAGCGGTACCGAGCTCGGATC
CAGCGGACCTAGGGAAACCTGCGGCCGCGGCTCCG
GAGGCTCCGGCGGGAGCGGCATGGACAAAGACTGCGAAATG
fSNAP-R ACAGATCTCGAGCTAACCCAGCCCAGGCTTGCCCAGTC
U1-70K-F AGAGATGGTACCATGACCCAGTTCCTGCCGCCCAAC
U1-70K-R ACAGATGCGGCCGCACTCCGGCGCAGCCTCCATC
U2B’-F AGAGATGGTACCATGGATATCAGACCAAATCATAC
U2B’-R ACAGATGCGGCCGCATTTCTTGGCGTATGTAATTTTC
Snu114-F AGAGATGGTACCATGGATACCGACTTATATGATGAG
Snu114-R ACAGATGCGGCCGCACATGGGGTAATTGAGCACAACATC
ligation splint ACATCGTCGACGGAAACCCTCGGAAACCCTGGACTACT
CTAGAAGTCATGCCCGCTTTTAGAGGGATCCATACTCA
CCTGGTAAGGTACCTCGCAGACAGCGATGCGGAAGAG
S1-T7-F TAATACGACTCACTATAGGGCGAATTCGAGCTCAC
S4-T7-F TAATACGACTCACTATAGGGTTTCCGTCGACGATGTCAGCTC
S1-R mCmAGACAGCGATGCGGAAG
S4-R mUmUGCATGCAGAGACCGCGAAG
2-color RNA Klenow splint GTTCCTTGCATGCAGAGACCGCGAAGAG/3ddC/
5i3 template-F TAATACGACTCACTATAGGGCGAATTCGAGCTCAC
5i3 template-R mUmUGCATGCAGAGACCGCGAAG
5i3 Klenow splint GTTCTTCTTATTGCATGCAGAGACCGCGAAGAG/3ddC/
5i3 Klenow capture CTCTTCGCGGTCTCTGCATGCAATAAGAAGAAC
3e5 template-F TAATACGACTCACTATAGGGCGAATTCGTCGACG
3e5 template-R mUmUGGAAACCCTCGGAAACCCTG
3e5 Klenow splint GTTCTTCTTATTGGAAACCCTCGGAAACCCTGGA/3ddC/
3e5 Klenow capture TCCAGGGTTTCCGAGGGTTTCCAATAAGAAGAAC
5i3e5 template-F TAATACGACTCACTATAGGGCGAATTC
5i3e5 template-R mUmUCATGCAATTGTCG
5i3e5 Klenow splint GTTCTTATCTTATTCATGCAATTGTCGGAAACCCTC/3ddC/
5i3e5 Klenow capture GAGGGTTTCCGACAATTGCATGAATAAGATAAGAAC
control-AMO CCTCTTACCTCAGTTACAATTTATA
anti-U1-AMO GGTATCTCCCCTGCCAGGTAAGTAT
DOI: https://doi.org/10.7554/eLife.37751.034
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together, our data suggest that the synergistic stimulatory effect of the downstream 5’SS on splicing
is exerted at the U2 recruitment step and the processes that enable it, not at the subsequent steps
of spliceosome assembly and splicing.
Inappropriate skipping of otherwise constitutive internal exons can occur with exceptionally low
frequency (~1 in 105 splicing events) (Fox-Walsh and Hertel, 2009). But the molecular mechanisms
contributing to this remarkable accuracy were previously unclear. By implementing CoSMoS in
extracts from human cells expressing genetically-tagged proteins, we here show that a major con-
tributor to exon inclusion is collaboration between flanking 5’SS. This collaboration dramatically
increases the rate of stable U2 recruitment during pre-spliceosome formation. Cross-intron and
cross-exon 5’SS synergy on U2 recruitment rate explains how U1 can have such a strong effect on
U2 recruitment despite its association with pre-mRNA being much more dynamic than U2. This
mechanism is likely crucial for rapid definition of internal exons in multi-intron RNAs, enabling the
human splicing machinery to avoid inappropriate exon skipping.
Materials and methods
Nuclear extract preparation
Stable HEK293 Tet-On Flp-In cell lines were generated to express fSNAP fusions of U1-70K, U2B’’,
and Snu114 at near endogenous levels as previously described (Singh et al., 2012). Stable HEK293
Tet-On Flp-In cell lines were generated from the Flp-In T-REx 293 Cell Line (Invitrogen, R78007).
The cells were purchased from Invitrogen and their resistance to Zeocin and their Flp-In competence
were confirmed. No further authentication or mycoplasma contamination testing were performed.
Plasmid pcDNA5-FRT-TetO-fSNAPc was generated by amplifying the open reading frame of fSNAP
using PCR primers fSNAP-F and fSNAP-R (Table 2) and inserting into pcDNA5-FRT-TetO (Invitrogen)
using the HindIII and XhoI restriction sites. Plasmids containing spliceosomal subcomplex protein-
Table 3. Plasmids.
Plasmid name Description
pcDNA5-FRT-TetO Singh et al. (2012)
pcDNA5-FRT-TetO-fSNAPc open reading frame of fSNAP inserted
into pcDNA5-FRT-TetO using the HindIII
and XhoI restriction sites
pcDNA5-FRT-TetO-U1-70K-fSNAPc open reading frame of U1-70K inserted
into pcDNA5-FRT-TetO-fSNAPc using
the KpnI and NotI restriction sites
pcDNA5-FRT-TetO-U2B’’-fSNAPc open reading frame of U2B’’ inserted
into pcDNA5-FRT-TetO-fSNAPc using
the KpnI and NotI restriction sites
pcDNA5-FRT-TetO-Snu114-fSNAPc open reading frame of Snu114 inserted
into pcDNA5-FRT-TetO-fSNAPc using
the KpnI and NotI restriction sites
PIP85.A (=T7-5i3) Moore and Sharp (1992),
T7 transcription template for 5i3
T7-3e5 T7 transcription template for 3e5
T7-5iX T7 transcription template for 5iX
T7-Xi3 T7 transcription template for Xi3
T7-3eX T7 transcription template for 3eX
T7-Xe5 T7 transcription template for Xe5
T7-5i3e5 T7 transcription template for 5i3e5
T7-5i3eX T7 transcription template for 5i3eX
T7-Xi3e5 T7 transcription template for Xi3e5
T7-Xi3eX T7 transcription template for Xi3eX
DOI: https://doi.org/10.7554/eLife.37751.033
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fSNAP fusions (Table 3) were generated by PCR amplification from HEK293 cDNA for U1-70K and
U2B’’, and from Kazusa DNA Research Institute cDNA clone ORK00375 (Nomura et al., 1994) for
Snu114 using the specified primers (Table 2) and cloning the products into pcDNA5-TetO-fSNAPc
using the KpnI and NotI restriction sites. Expression levels of the fSNAP fusion proteins were
adjusted to endogenous level by inducing the U1-70K-fSNAP, U2B’’-fSNAP, and Snu114-fSNAP Flp-
In cell lines with 6 ng/ml, 3 ng/ml, and 3 ng/ml Doxycycline (BD Biosciences, 631311), respectively.
Parental cells were not induced. Nuclear extracts were prepared as previously described (Lee et al.,
1988). In brief, HEK293 cells were grown at 37˚C 5% CO2 in DMEM medium supplemented with
10% FBS. Cells from 10 confluent 15 cm dishes were harvested and washed with ice cold PBS. Cells
(900 ml) were resuspended in 900 ml Buffer A [10 mM Tris, 1.5 mM MgCl2, 10 mM KCl and 0.5 mM
DTT, pH 7.9 at 4˚C, supplemented with complete protease inhibitor cocktail (Roche, 04693159001)],
transferred to a 2 ml Eppendorf tube, incubated for on ice 15 min and then disrupted by 10 pas-
sages through a 25 gauge needle. After centrifuging the lysate for 20 s at 12,000  g, the nuclear
pellet was resuspended in 450 ml Buffer C [20 mM Tris, 25% (v/v) glycerol, 0.42 M NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA and 0.5 mM DTT, pH 7.9 at 4˚C, supplemented with complete protease inhibi-
tor cocktail (Roche, 04693159001)] and rapidly stirred in a 2 ml round-bottom microcentrifuge tube
with a 12.7  3 mm stir bar for 30 min. After clarifying the lysate by centrifuging for 10 min at
12,000  g, the SNAP-Surface 549 dye-benzylguanine conjugate (New England BioLabs, S9112S)
was added to the supernatant at a final concentration of 200 nM and incubated for 30 min at 30˚C.
After labeling, the supernatant was dialyzed 2 times for 2 hr each against Buffer E (20 mM Tris, 20%
(v/v) glycerol, 0.1 M KCl, 0.2 mM EDTA and 0.5 mM DTT, pH 7.9 at 4˚C). The dialysate (1 ml) was
spun again for 10 min at 16,000  g and frozen in liquid nitrogen. Typical total protein concentration
was 8.5 mg/ml. For negative control experiments, extracts were depleted of ATP using Centri-sep
spin columns (Princeton Separations, CS-901) (Anderson and Moore, 2000). A single preparation of
each of the three extracts was used in all reported experiments.
RNA preparation
Radioactively labeled pre-mRNA substrate PIP85A (Table 1) was synthesized by in vitro transcription
as previously described with a m7G(5’)ppp(5’)G 5’ cap and [a-32P]UTP (Moore and Sharp, 1992).
Two color pre-mRNAs carrying a 3’ biotin (Figure 1C) were prepared by splinted ligation as previ-
ously described (Crawford et al., 2013; Shcherbakova et al., 2013) using DNA oligonucleotides
and RNA segments listed in Tables 1 and 2. Specifically, RNA segments S1 (with a m7G(5’)ppp(5’)G
5’ cap) and S4 were produced in vitro by transcription by T7 RNA polymerase of templates gener-
ated by PCR from the plasmid PIP85A using the PCR primers S1-T7-F and S1-R or S4-T7-F and S4-R
respectively. S2 and S3 were purchased from Dharmacon. Prior to the ligation 5’ ends of S2, S3 and
S4 were phosphorylated and S3 was labeled with AlexaFluor 647 NHS ester (Thermo Scientific,
A20006) as previously described (Crawford et al., 2013; Shcherbakova et al., 2013). For the final
splinted ligation S1, S2, S3, S4 RNA segments and the ligation splint oligonucleotide were annealed.
The ligation resulted in an RNA where the 5’ exon was labeled with a single green-excited dye
(DY547) at position  7 relative to the 5’SS, the intron was labeled with on average two red-excited
dyes (AlexaFluor 647) at positions 18, 30 and/or 42 relative to the 5’SS, and a single biotin was
added to the 3’ end by Klenow extension with biotin-dCTP (Trilink Bio Technologies Inc, N5002)
(Braun and Serebrov, 2017; Shcherbakova et al., 2013).
One-color pre-mRNAs (Figures 2, 3 and 4) were labeled at the 3’ end by Klenow extension with
both AlexaFluor 647 dUTP (Life Technologies, A32763) and biotin dCTP, resulting in one (5i3 and
3e5) or two (5i3e5) AlexaFluor 647 dyes and one biotin per pre-mRNA molecule. All oligonucleotides
used for Klenow extensions are listed in Tables 1 and 2.
Western blotting
Protein samples were separated by SDS-PAGE and transferred to a 0.45 mm pore size nitrocellulose
membrane (Whatman, PROTRAN BA 85, 10 401 196). Proteins were detected using the indicated
antibodies and an Odyssey CLx Imager (LI-COR) according to manufacturer’s instructions.
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Co-immunoprecipitation
Cells (one 15 cm dish per condition) were lysed in 3 ml Buffer 1 (10 mM Tris pH 7.4, 100 mM NaCl,
2.5 mM MgCl2) supplemented with 40 mg/ml digitonin. Nuclei were collected by pelleting at 2,000
 g for 10 min and resuspended in 3 ml Buffer 1 supplemented with 0.1% Triton X-100 and com-
plete protease inhibitor cocktail (Roche, 04693159001). The suspension was sonicated (Branson Digi-
tal Sonifier-250) for 8 s in bursts of 2 s and the NaCl concentration adjusted to 150 mM. This nuclear
lysate was clarified by centrifugation at 15,000  g for 10 min and an input sample taken. Dynabeads
Protein A (Life Technologies, 10002D) or Protein G (Life Technologies, 10001D) pre-incubated with
respective antibodies were added and nutated for 2 hr. After four washes with Buffer 2 (20 mM Tris
pH 7.4, 150 mM NaCl, 0.1% NP-40), bound proteins were eluted with SDS loading dye and analyzed
by Western blotting as described above.
Fluorescence and Coomassie gels
Protein samples were separated by denaturing polyacrylamide gel electrophoresis (SDS-PAGE). Gels
were fixed in 25% isopropanol and 10% acetic acid, and fluorescence was imaged using a Typhoon
scanner (GE Healthcare). Gels were subsequently stained with Coomassie Brilliant Blue dye R-250
(Thermo Scientific, 20278) to visualize total protein.
Bulk in vitro splicing assays
Splicing reactions were performed at 30˚C in 20 ml of 40% HEK 293 nuclear extract in final concentra-
tions of 60 mM K+-MOPS pH 7.3, 2 mM ATP, 0.5 mM DTT, 2 mM MgOAc2, 20 mM potassium gluta-
mate, 5 mM creatine phosphate, and 0.1 mg/ml E.coli tRNA with 20 fmol radioactively labeled pre-
mRNA substrate. To make conditions correspond to those in the CoSMoS experiments, the bulk
assays also included 0.9 U/ml B. cepacia protocatechuate dioxygenase (Sigma P8279; 5 U/mg; 9
mg/ml) and 5 mM protocatechuate (Sigma 37580, recrystallized from hot water before use) as an O2
scavenging system and 1 mM Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid,
Aldrich, 23,881–3) as a triplet quencher (Hoskins et al., 2011). Where indicated, anti-U1 AMO or
control AMO (Gene Tools, sequences are described in Table 2) were added at 10 mM final concen-
tration as previously described (Kaida et al., 2010) and the splicing reaction was 20 min pre-incu-
bated at 30˚C prior to the addition of pre-mRNA substrate. After incubating at 30˚C for times
indicated, splicing reactions were stopped by adding 10 volumes of Stop Buffer (100 mM Tris-Cl-, 10
mM EDTA, 1% SDS, 150 mM NaCl, and 300 mM sodium acetate, pH 7.5). RNAs were extracted and
separated by denaturing polyacrylamide (15%) gel electrophoresis. The dried gel was phosphorim-
aged with a Typhoon PhosphorImager and RNAs quantified using ImageQuant with signal intensities
being normalized to their U content. Splicing efficiencies were calculated as the ratio of spliced RNA
product (i.e., ligated exons) to pre-mRNA starting material at time zero.
Single molecule in vitro splicing assays
Glass slides and cover slips were prepared as described previously (Friedman et al., 2006) except
that PEGylation was only allowed to proceed for 3 hr at room temperature after which slides and
coverslips were washed with 50 mM potassium phosphate buffer pH 7.4, dried with N2 gas and
stored at  80˚C until use. After assembly of reaction chambers with vacuum grease (up to five lanes
per slide with a volume of ~25 ml each), individual lanes were rehydrated immediately before use
with 50 mM potassium phosphate buffer pH 7.4.
Single-molecule fluorescence imaging used a micro-mirror total internal reflection fluorescence
(TIRF) microscope with automatic focus (Friedman et al., 2006; Hoskins et al., 2011). Sample tem-
perature was maintained at 30˚C using a custom-built temperature control system
(Paramanathan et al., 2014). Streptavidin-conjugated fluorescent beads (Life Technologies, T10711)
were tethered to the surface (multiple beads per field of view) and were used as reference for stage
drift correction. RNAs were tethered on the slide surface at a total density of ~0.2–0.5 fluorescent
spots per mm2. When multiple different RNA species were tethered sequentially, a microscope
image was taken after each round of deposition to individually identify the molecules of each RNA
species. Splicing reactions (60 ml) were assembled as described for the bulk assays above (but with-
out pre-mRNA) and introduced into individual slide lanes by capillary action and wicking; imaging
was initiated immediately after reaction loading. For experiments with the two color pre-mRNA we
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acquired a 1 s duration frame every 5 min with 150 mW 633 nm (red) excitation except at the begin-
ning and end of the experiment when we acquired one frame per second with 300 mW 532 nm
(green) excitation. For experiments with the one color pre-mRNAs and labeled nuclear extracts we
acquired sequences of 100 one-second duration frames with 300 mW 532 nm excitation alternating
with a single one-second frame with 150 mW 633 nm excitation. All excitation powers are measured
incident to the input micro-mirror.
Single molecule data analysis
Data analysis was performed using custom software (https://github.com/gelles-brandeis/CoSMoS_
Analysis; copy archived at https://github.com/elifesciences-publications/CoSMoS_Analysis) imple-
mented in MATLAB (MathWorks) as previously described (Friedman and Gelles, 2015;
Hoskins et al., 2011); locations of fluorescent spots were identified by image analysis using the
spot-picker algorithm (Friedman and Gelles, 2015). Locations of tethered RNA molecules and con-
trol locations were determined in drift-corrected, color-aligned images. For spliceosomal subcom-
plex detection, images were averaged with a five frame sliding window before spot picking. Binding
frequencies were calculated as described (Friedman and Gelles, 2015). The provided source data
files are ‘intervals’ files readable by imscroll (https://github.com/gelles-brandeis/CoSMoS_Analysis).
The time-averaged specific occupancy of RNA molecules by a spliceosomal subcomplex (i.e., the
fraction of time the RNA a fluorescently labeled subcomplex is bound to the RNA) was calculated as
(fm - fc) / (1 - fc) where the subscripts m and c refer to RNA and no RNA control locations, respec-
tively, and f represents the fraction of time that a fluorescent spot was present, averaged over all
locations measured for each type. Note that this value underestimates the subcomplex occupancy
since only a fraction of each subcomplex is labeled (Figure 1—figure supplement 4). Standard error
of the fractional occupancy was determined by bootstrapping (2,000 random samples). Distributions
of time to first binding event were fit to background-corrected single-exponential models as
described (Friedman and Gelles, 2015).
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